Volitionrx Current Deferred Revenue from 2010 to 2025
| VNRX Stock | USD 0.55 0.04 7.84% |
Current Deferred Revenue | First Reported 2013-12-31 | Previous Quarter 22.9 M | Current Value 22.9 M | Quarterly Volatility 7.3 M |
Check Volitionrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Volitionrx's main balance sheet or income statement drivers, such as Interest Expense of 267.6 K, Other Operating Expenses of 44.4 M or Total Operating Expenses of 44.4 M, as well as many indicators such as Price To Sales Ratio of 71.97, Dividend Yield of 0.0 or Days Sales Outstanding of 122. Volitionrx financial statements analysis is a perfect complement when working with Volitionrx Valuation or Volatility modules.
Volitionrx | Current Deferred Revenue |
Latest Volitionrx's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Volitionrx over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Volitionrx's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Volitionrx's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Volitionrx Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 5,546,729 | |
| Geometric Mean | 344,363 | |
| Coefficient Of Variation | 186.66 | |
| Mean Deviation | 8,129,448 | |
| Median | 216,894 | |
| Standard Deviation | 10,353,549 | |
| Sample Variance | 107.2T | |
| Range | 27.8M | |
| R-Value | 0.74 | |
| Mean Square Error | 52.3T | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | 1,604,418 | |
| Total Sum of Squares | 1607.9T |
Volitionrx Current Deferred Revenue History
About Volitionrx Financial Statements
Volitionrx investors use historical fundamental indicators, such as Volitionrx's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Volitionrx. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 26.4 M | 27.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Volitionrx Stock Analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.